Compare UI & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UI | TEVA |
|---|---|---|
| Founded | 2003 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.8B | 30.2B |
| IPO Year | 2011 | N/A |
| Metric | UI | TEVA |
|---|---|---|
| Price | $577.00 | $28.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $587.50 | $27.00 |
| AVG Volume (30 Days) | 161.9K | ★ 11.4M |
| Earning Date | 11-07-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.55% | N/A |
| EPS Growth | ★ 102.50 | N/A |
| EPS | ★ 13.07 | 0.62 |
| Revenue | $2,756,974,000.00 | ★ $16,776,000,000.00 |
| Revenue This Year | $15.29 | $4.74 |
| Revenue Next Year | $8.93 | $0.48 |
| P/E Ratio | ★ $44.22 | $46.12 |
| Revenue Growth | ★ 36.77 | 0.02 |
| 52 Week Low | $255.00 | $12.47 |
| 52 Week High | $803.60 | $28.68 |
| Indicator | UI | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 43.95 | 80.93 |
| Support Level | $540.17 | $24.01 |
| Resistance Level | $579.92 | $26.96 |
| Average True Range (ATR) | 25.54 | 0.68 |
| MACD | 5.44 | 0.19 |
| Stochastic Oscillator | 88.84 | 94.65 |
Ubiquiti Inc is a seller of equipment and provides the related software platforms through web stores. The group develops technology platforms for high-capacity distributed Internet access, unified information technology, and consumer electronics for professional, home, and personal use. Its solutions are: high-performance networking technology for enterprises, service providers, and consumers. target the enterprise and service provider markets through a community of service providers, distributors, value-added resellers, webstores, systems integrators, and corporate IT professionals, which it refers to as the Ubiquiti Community. It targets consumers through digital marketing, including through webstores, retail chains, and, to a lesser extent, the Ubiquiti Community.
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.